Marked increase in serum KL-6 and surfactant protein D levels during the first 4 weeks after treatment predicts poor prognosis in patients with active interstitial pneumonia associated with polymyositis/dermatomyositis

• ARAI Satoko

  Clinical Immunology, Dokkyo Medical University

• KURASAWA Kazuhiro

  Clinical Immunology, Dokkyo Medical University

• MAEZAWA Reika

  Clinical Immunology, Dokkyo Medical University

• OWADA Takayoshi

  Clinical Immunology, Dokkyo Medical University

• OKADA Harutsugu

  Clinical Immunology, Dokkyo Medical University

• FUKUDA Takeshi

  Clinical Immunology, Dokkyo Medical University

収録刊行物

• Modern rheumatology

  Modern rheumatology 23 (5), 872-883, 2013-09-01

キーワード

• KL-6
• SP-D
• Interstitial pneumonia
• Prognosis
• PM
• DM

詳細情報

• CRID: 1571417126137080576
• NII論文ID: 10031201142
• NII書誌ID: AA1157187X
• ISSN: 14397595
• Web Site: https://search.jamas.or.jp/link/ui/2014315927
• 本文言語コード: en
• データソース種別:
  • CiNii Articles